BioCentury
ARTICLE | Clinical News

ApoStream diagnostic data

April 30, 2012 7:00 AM UTC

Data from blood samples of patients with HCC showed that ApoCell's ApoStream isolated a greater number of CTCs compared to Veridex LLC's CellSearch Circulating Tumor Cell Kit. Data were presented at the American Association for Cancer Research meeting in Chicago. ApoCell said it plans to deliver ApoStream alpha prototype units to the National Cancer Institute this year. ApoStream CTC analysis is also being used for pharmacodynamic analysis in a Phase I trial evaluating sorafenib in combination with vorinostat to treat advanced HCC. ...